| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 核苷类产品(元) | - | - | 90,916,614.33 | 190,236,489.13 | 101,670,843.43 |
| 医药中间体(元) | 81,897,182.36 | 198,811,092.97 | 84,942,234.59 | 179,161,426.31 | 91,032,883.91 |
| 核苷类(元) | 90,844,069.01 | 176,232,421.05 | - | - | - |
| 其他产品(元) | - | - | 69,063,037.39 | 140,046,137.83 | 54,022,472.15 |
| 其他类(元) | 95,954,147.88 | 82,562,279.62 | - | - | - |
| 营业成本(元) | |||||
| 核苷类产品(元) | - | - | 51,648,588.89 | 139,807,489.25 | 106,554,429.00 |
| 医药中间体(元) | 68,673,180.59 | 178,249,385.92 | 73,829,319.12 | 162,006,485.17 | 80,262,294.08 |
| 核苷类(元) | 71,704,123.87 | 100,820,386.05 | - | - | - |
| 其他产品(元) | - | - | 69,578,593.43 | 176,859,142.07 | 53,874,134.79 |
| 其他类(元) | 84,429,726.82 | 85,333,362.02 | - | - | - |
| 毛利(元) | |||||
| 核苷类产品(元) | - | - | 39,268,025.44 | 50,428,999.88 | -4,883,585.57 |
| 医药中间体(元) | 13,224,001.77 | 20,561,707.05 | 11,112,915.47 | 17,154,941.14 | 10,770,589.83 |
| 核苷类(元) | 19,139,945.14 | 75,412,035.00 | - | - | - |
| 其他产品(元) | - | - | -515,556.04 | -36,813,004.24 | 148,337.36 |
| 其他类(元) | 11,524,421.06 | -2,771,082.40 | - | - | - |
| 毛利率(%) | |||||
| 核苷类产品(%) | - | - | 43.19 | 26.51 | -4.80 |
| 医药中间体(%) | 16.15 | 10.34 | 13.08 | 9.58 | 11.83 |
| 核苷类(%) | 21.07 | 42.79 | - | - | - |
| 其他产品(%) | - | - | -0.75 | -26.29 | 0.27 |
| 其他类(%) | 12.01 | -3.36 | - | - | - |
| 收入构成(%) | |||||
| 核苷类产品(%) | - | - | 37.12 | 37.34 | 41.21 |
| 医药中间体(%) | 30.48 | 43.45 | 34.68 | 35.17 | 36.90 |
| 核苷类(%) | 33.81 | 38.51 | - | - | - |
| 其他产品(%) | - | - | 28.20 | 27.49 | 21.90 |
| 其他类(%) | 35.71 | 18.04 | - | - | - |
| 毛利构成(%) | |||||
| 核苷类产品(%) | - | - | 78.75 | 163.89 | -80.92 |
| 医药中间体(%) | 30.13 | 22.06 | 22.29 | 55.75 | 178.46 |
| 核苷类(%) | 43.61 | 80.91 | - | - | - |
| 其他产品(%) | - | - | -1.03 | -119.64 | 2.46 |
| 其他类(%) | 26.26 | -2.97 | - | - | - |